Compare · INGM vs WGS
INGM vs WGS
Side-by-side comparison of Ingram Micro Holding Corporation (INGM) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INGM and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- INGM is the larger of the two at $6.85B, about 4.4x WGS ($1.54B).
- Over the past year, INGM is up 54.5% and WGS is down 29.9% - INGM leads by 84.3 points.
- INGM has been more active in the news (11 items in the past 4 weeks vs 5 for WGS).
- INGM has more recent analyst coverage (22 ratings vs 8 for WGS).
PerformanceINGM+54.48%WGS-29.87%
2025-06-02+0.00%2026-06-01
- Company
- Ingram Micro Holding Corporation
- GeneDx Holdings Corp.
- Price
- $29.50+4.42%
- $52.00+0.24%
- Market cap
- $6.85B
- $1.54B
- 1M return
- -4.08%
- -17.17%
- 1Y return
- +54.48%
- -29.87%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NYSE
- NASDAQ
- IPO
- 2024
- 2020
- News (4w)
- 11
- 5
- Recent ratings
- 22
- 8
Latest INGM
- Ingram Micro Holding Corp. upgraded by Analyst with a new price target
- Banzai International, Inc. Expands Market Reach, Announces Strategic Alliance with Ingram Micro
- Amendment: SEC Form SCHEDULE 13G/A filed by Ingram Micro Holding Corporation
- Director Ashmore Craig W was granted 7,031 shares (SEC Form 4)
- Director Wienbar Sharon L was granted 7,031 shares, increasing direct ownership by 39% to 25,055 units (SEC Form 4)
- Director Haussler Jakki L. was granted 7,031 shares, increasing direct ownership by 39% to 25,055 units (SEC Form 4)
- Director Stone Heisz Leslie was granted 7,031 shares, increasing direct ownership by 39% to 25,055 units (SEC Form 4)
- Director Alvaro Felicia was granted 7,031 shares, increasing direct ownership by 28% to 32,039 units (SEC Form 4)
- Director Monie Alain was granted 7,031 shares, increasing direct ownership by 39% to 25,055 units (SEC Form 4)
- SEC Form 8-K filed by Ingram Micro Holding Corporation
Latest WGS
- GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
- Director Casdin Capital, Llc bought $21,459,736 worth of shares (500,000 units at $42.92) (SEC Form 4)
- Director Meister Keith A. bought $13,765,345 worth of shares (351,273 units at $39.19) (SEC Form 4)
- Director Meister Keith A. bought $46,806,729 worth of shares (1,205,147 units at $38.84) (SEC Form 4)
- SEC Form 4 filed by Director Casdin Capital, Llc
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $141,595 worth of shares (2,172 units at $65.19), increasing direct ownership by 2% to 93,216 units (SEC Form 4) (for tax liability)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 754 shares and sold $25,555 worth of shares (392 units at $65.19), increasing direct ownership by 1% to 34,942 units (SEC Form 4) to satisfy withholding tax